TrialJapanese journal of ophthalmology2024

Safety and efficacy of a novel 0.5% epinastine topical eyelid cream in allergic conjunctivitis: a phase 3 trial.

Hiroshi Fujishima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.